Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Innovate Corp. (VATE) Stock Forecast & Price Prediction United States | NYSE | Industrials | Engineering & Construction
$5.30
-0.06 (-1.12%)Did VATE Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Elev8 Brands is one of their latest high-conviction picks.
VATE has shown a year-to-date change of 7.3% and a 1-year change of -5.4%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for VATE. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for VATE.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
The following stocks are similar to Elev8 Brands based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Innovate Corp. has a market capitalization of $70.40M with a P/E ratio of -1.7x. The company generates $1.07B in trailing twelve-month revenue with a -3.9% profit margin.
Revenue growth is -13.0% quarter-over-quarter, while maintaining an operating margin of +1.2% and return on equity of +22.4%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
A diversified holding company in industrial and financial services.
The company generates revenue by acquiring and managing a portfolio of subsidiary companies in the industrial services and financial services sectors. It focuses on operational efficiencies and strategic growth, leveraging expertise in engineering, construction, maintenance, insurance, and asset management to serve both businesses and individuals.
Innovate Corp. is positioned to capitalize on emerging market trends through strategic acquisitions and innovative management practices, enhancing value creation across its diverse operations. Its impact spans critical sectors like infrastructure and energy, making it a key player in both industrial growth and financial solutions.
Industrials
Engineering & Construction
3,135
United States
2021
INNOVATE Corp. (NYSE: VATE) announced a $5.5 million dividend from its subsidiary DBM Global Inc., equating to $1.42 per share, payable June 16, 2025, to DBMG stockholders as of June 2, 2025.
DBM Global's cash dividend signals strong financial health, enhancing INNOVATE Corp.'s liquidity and potential for reinvestment, impacting overall company valuation positively.
INNOVATE Corp. (NYSE: VATE) announced that DBM Global Inc. has secured an $85 million term loan and a $135 million revolving credit facility to repay existing debts and enhance working capital.
The amended credit agreement for DBM Global Inc. enhances liquidity and reduces debt, potentially improving financial stability and operational flexibility, which can positively impact INNOVATE Corp.'s stock performance.
INNOVATE Corp. (NYSE: VATE) will host its Q1 2025 Earnings Conference Call on May 6, 2025, at 4:30 PM ET, featuring key executives including the interim CEO and CFO.
The Q1 2025 earnings call indicates INNOVATE Corp.'s financial performance and strategic direction, influencing stock valuation and investor sentiment.
DBM Global reported Q1 revenue of $264.9 million. MediBeacon's TGFR System received FDA approval. Spectrum anticipates revenue from datacasting by year-end.
DBM Global's revenue indicates strong demand in infrastructure. MediBeacon's FDA approval boosts its market potential, while Spectrum's datacasting opportunities could enhance future earnings.
INNOVATE Corp. (NYSE: VATE) will release its Q1 2025 financial results on May 6, 2025, after market close, followed by a conference call at 4:30 p.m. ET.
The scheduled earnings release and conference call for INNOVATE Corp. will provide insights into its financial health and future strategy, influencing investor sentiment and stock performance.
INNOVATE Corp. (NYSE: VATE) will hold its Q4 2024 earnings conference call on March 31, 2025, at 4:30 PM ET, featuring key executives from the company.
The earnings call provides insights into INNOVATE Corp's financial performance and strategic direction, influencing market sentiment and investment decisions.
Analyst forecasts for Innovate Corp. (VATE) are not currently available. The stock is trading at $5.30.
Analyst ratings for VATE are not currently available. The stock is currently trading at $5.30. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for VATE are not currently available. The stock is trading at $5.30.
The company generates revenue by acquiring and managing a portfolio of subsidiary companies in the industrial services and financial services sectors. It focuses on operational efficiencies and strategic growth, leveraging expertise in engineering, construction, maintenance, insurance, and asset management to serve both businesses and individuals.
Price targets from Wall Street analysts for VATE are not currently available. The stock is trading at $5.30.
Price targets from Wall Street analysts for VATE are not currently available. The stock is trading at $5.30.
Analyst ratings for VATE are not currently available. The stock is trading at $5.30.
Stock price projections, including those for Innovate Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.